Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: A pediatric brain tumor consortium study

Authors

Amar Gajjar, University of Tennessee
Clinton F. Stewart, St. Jude Children's Research Hospital, Memphis, TNFollow
David W. Ellison, St. Jude Children's Research Hospital, Memphis, TN
Sue Kaste
Larry E. Kun
Roger J. Packer, George Washington UniversityFollow
Stewart Goldman, Lurie Children's Hospital of Chicago, Chicago, IL
Murali Chintagumpala
Dana Wallace
Naoko Takebe
James M. Boyett
Richard J. Gilbertson
Tom Curran

Document Type

Journal Article

Publication Date

11-2013

Journal

Clinical Cancer Research

Volume

Volume 19, Issue 22

Inclusive Pages

6305-6322

Comments

PMCID: PMC3856244 [Available on 2014/11/15]

APA Citation

Gajjar, A., Stewart, C.F., Ellison, D.W., Kaste, S., Kun, L.E. et al. (2013). Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study. Clinical Cancer Research, 19(22), 6305-6322.

Peer Reviewed

1